4//SEC Filing
DENYES NANCY 4
Accession 0000950170-25-004131
CIK 0001339970other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:01 PM ET
Size
5.5 KB
Accession
0000950170-25-004131
Insider Transaction Report
Form 4
aTYR PHARMA INCATYR
DENYES NANCY
General Counsel
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-08+275,000→ 275,000 totalExercise: $3.74Exp: 2035-01-08→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning February 8, 2025, such that this option will be fully exercisable on January 8, 2029. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001640869
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:01 PM ET
- Size
- 5.5 KB